Developing and Piloting a Multi-component Technology-based Care Intervention to Address Patient Symptoms and Caregiver Burden in Home Hospice. Phase 1.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04074304|
Recruitment Status : Suspended (Temporarily paused due to COVID-19 and will resume based on guidance of public health authorities. This is not a suspension of IRB approval)
First Posted : August 30, 2019
Last Update Posted : May 28, 2020
|Condition or disease||Intervention/treatment||Phase|
|Home Hospice||Other: I-HoME||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||30 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Developing and Piloting a Multi-component Technology-based Care Intervention to Address Patient Symptoms and Caregiver Burden in Home Hospice|
|Estimated Study Start Date :||July 1, 2020|
|Estimated Primary Completion Date :||November 2020|
|Estimated Study Completion Date :||November 2020|
Participants will be shown prototype of I-HoME and provide feedback as part of the user-center design process.
A multi-component technology-based care intervention.
- Participants' experience using the intervention as measured by the I-HoME User-centered design questionnaire [ Time Frame: 1 day ]A questionnaire consisting of open ended questions asking participants to provide feedback and their thoughts about the I-HoME intervention. The responses gathered are not scored, but qualitative analysis will be performed to identify issues that will be used to make revisions to the I-HoME intervention before starting phase 2 of the project.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04074304
|United States, New York|
|The Visiting Nurse Service of New York|
|New York, New York, United States, 10017|
|Principal Investigator:||Veerawat Phongtankuel, MD, MS||Weill Cornell Medicine|